Minerva Neurosciences Inc...

NASDAQ: NERV · Real-Time Price · USD
2.26
0.46 (25.91%)
At close: Aug 15, 2025, 3:59 PM
2.32
2.85%
After-hours: Aug 15, 2025, 07:47 PM EDT

Minerva Neurosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
21.36M 40.91M 36.09M 60.76M
Short-Term Investments
100K 100K n/a n/a
Long-Term Investments
21.34B -28.01M n/a n/a
Other Long-Term Assets
n/a 56.02M -891 -51.08K
Receivables
n/a n/a 3.12M n/a
Inventory
n/a n/a -3.02M n/a
Other Current Assets
906.89M 1.09M 848.12K 100K
Total Current Assets
22.27M 42M 40.16M 62.2M
Property-Plant & Equipment
n/a 10.88K 16.33K 51.08K
Goodwill & Intangibles
14.87M 14.89M 14.91M 14.92M
Total Long-Term Assets
14.87M 14.9M 14.93M 14.92M
Total Assets
37.14M 56.9M 55.09M 77.12M
Account Payables
1.61M 1.81M 969.67K 1.85M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
1.23M 944.33K 393.08K n/a
Total Current Liabilities
2.84M 3.34M 1.38M 2.82M
Long-Term Debt
n/a 82.02M 73.73M n/a
Other Long-Term Liabilities
60B 862.00 n/a 66.33M
Total Long-Term Liabilities
60B 82.02M 73.73M 66.33M
Total Liabilities
62.84M 85.36M 75.11M 69.15M
Total Debt
n/a 82.02M 73.73M n/a
Common Stock
699.00 699.00 534.00 4.27K
Retained Earnings
-395.38B -396.82M -366.81M -334.7M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
-25.69B -28.46M -20.02M 7.98M
Total Investments
21.34B -27.91M n/a n/a